Jazz Pharmaceuticals PLC (JAZZ) P/E ratio history

$214.00

Latest weekly close · Market cap $14.9B

Share JAZZ P/E history
Below its usual range

As of

JAZZ's P/E of 14.6x is lower than 88% of its weekly readings since November 2023.

Weekly P/E since November 2023

P/E each weekMiddle half of its readingsMedian 18.0×
P/E weekly history0×50×100×150×200×14.6×20222023202420252026
Median
18.0×
Low to high
11.6×–153.8×
Versus median
-19%
History starts
November 2023

P/E

12thpercentile

of its weekly readings since November 2023

Below its usual range

Growth, last 12 months vs the year before

Revenue
+13%accelerating
EPS
n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
-1,00001,0002,00020222023202420252026

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

JAZZ P/E at each year-end
Year-endP/E5-year percentile
n/aToo little history
17.0×13
143.0×100
n/aToo little history
n/aToo little history
52.1×95
14.0×6
15.2×1
22.2×30
19.1×26

Loading peers and related research…

About this history

What is JAZZ's current P/E?
JAZZ's P/E of 14.6x is lower than 88% of its weekly readings since November 2023.
What is JAZZ's five-year median P/E?
18.0x. Half of JAZZ's weekly readings since November 2023 were higher and half were lower. This page has 765 weekly readings, from Feb 27, 2012 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares JAZZ only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built